10-K Decoder · All companies

Trevi Therapeutics, Inc.

TRVI · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$0K$0K
Operating income−$49.3M−$51.5M+4.3%
Net income−$42.8M−$47.9M+10.7%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 9, 2026

$Q3 2026Year earlierChange
Revenue$0K$0K
Operating income−$24.5M−$13.9M−76.3%
Net income−$21.5M−$11.8M−82.2%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Trevi Therapeutics's revenue in FY2025?
$0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Mar 2026.
Was Trevi Therapeutics profitable in FY2025?
No: net income was −$42.8M and operating income −$49.3M in FY2025.
What was Trevi Therapeutics's revenue in Q3 2026?
$0K (n/a vs a year earlier), per its Form 10-Q filed Nov 9, 2026.